Sai Parenterals IPO Review: A Deep Dive into the Pharma Injectables Issue
As of March 22, 2026, the Indian primary market is shifting its focus toward specialized healthcare with the launch of the Sai Parenterals IPO. Operating in the high-barrier “Parenterals” (injectable) segment, the Hyderabad-based company is looking to raise approximately ₹125 crore through a fresh issue of shares. Sai Parenterals IPO: Everything You Need to Know […]












